A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders.
J Allergy Clin Immunol
; 132(3): 713-722.e11, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-23791505
Palavras-chave
Alloreactivity; CD8; CON; CTL; Cytotoxic T lymphocyte; Dissociation constant; GNLY; GVHD; Graft-versus-host disease; Granulysin; K(d); NF-κB; NK; Natural killer; Nonsilencing control; Nuclear factor κB; RNA interference; RNAi; SEAP; SELEX; SJS; Secreted embryonic alkaline phosphatase; Single-stranded DNA; Small interfering RNA; Stevens-Johnson syndrome; Systematic evolution of ligands by exponential enrichment; T-cell receptor; TCR; TEN; Toxic epidermal necrolysis; aptamer; drug hypersensitivity; graft-versus-host disease; granulysin; nucleic acidbased therapeutics; siRNA; ssDNA; systematic evolution of ligands by exponential enrichment; toxic epidermal necrolysis
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Linfócitos T Citotóxicos
/
Antígenos de Diferenciação de Linfócitos T
/
Antígenos CD8
/
RNA Interferente Pequeno
/
Aptâmeros de Nucleotídeos
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Taiwan